Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UKMerryn Voysey, Angela M. Minassian, Sue Ann Costa Clemens et al.|The Lancet|2020Cited by 5k
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trialsMerryn Voysey, Angela M. Minassian, Sue Ann Costa Clemens et al.|The Lancet|2021Cited by 1.2k
Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) VaccineMerryn Voysey, Alastair McGregor, Sue Ann Costa Clemens et al.|SSRN Electronic Journal|2021Cited by 31
Isolate differences in colonization efficiency during experimental human pneumococcal challengeSherin Pojar, Daniela M. Ferreira, Ankur B. Dalia et al.|medRxiv|2020Cited by 2